Skip to page content

This document has been developed to assist management of Immune Cell Associated Neurotoxicity Syndrome (ICANS) in patients receiving bispecific antibody therapy.

Printable version of this page

ICANS (Immune Cell Associated Neurotoxicity Syndrome) Guideline Department: Haematology PDF, 267.8 KB, 7 pages